Corbus Pharmaceuticals competitors

Corbus Pharmaceuticals Competitors include Rigel Pharmaceuticals, Novartis, GlaxoSmithKline and Bristol-Myers Squibb.
Add company...
Corbus Pharmaceuticals
Corbus Pharmaceuticals
Corbus Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company.
Rigel Pharmaceuticals
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Novartis
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Founding Date
Founding Date
2009
Founding Date
1996
Founding Date
1996
Founding Date
2000
Founding Date
1887
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Norwood, US HQ
Locations
South San Francisco, US HQ
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
Brentford, GB HQ
Locations
New York, US HQ
Vienna, AT
Braine L'alleud, BE
Calgary, CA
Edmonton, CA
Montreal, CA
Toronto, CA
see more
Employees
Employees
25
Employees
77
Employees
126,0004% increase
Employees
98,462
Employees
23,700
Valuation ($)
Valuation ($)
381.8 m
Valuation ($)
478.3 m
Valuation ($)
175.5 b
Valuation ($)
101.9 b
Valuation ($)
84.9 b
Twitter followers
Twitter followers
2.9 k
Twitter followers
1.3 k
Twitter followers
234.4 k
Twitter followers
163.4 k
Twitter followers
120.8 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
£30.2b (FY, 2017)
Revenue (est.)
$20.8b (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$17.2b (FY, 2017)
Cost of goods
£10.3b (FY, 2017)
Cost of goods
$6.1b (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$31.9b (FY, 2017)
Gross profit
£19.8b (FY, 2017)
Gross profit
$14.7b (FY, 2017)
Net income
Net income
($32.4m) (FY, 2017)
Net income
($78m) (FY, 2017)
Net income
$7.7b (FY, 2017)
Net income
£2.2b (FY, 2017)
Net income
$975m (FY, 2017)

Operating

Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
8 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 12.7m
Total funding raised
$ 130m
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
$ 15.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
77

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,700

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

View company